Sphera Funds Management Ltd. Clovis Oncology, Inc. Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$42.06 - $62.4 $7.07 Million - $10.5 Million	-168,000 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$50.12 - $67.72 $501,200 - $677,200	10,000 Added 6.33%	168,000 $8.87 Million
Q3 2017 Nov 09, 2017	BUY	$67.17 - $84.81 $10.6 Million - $13.4 Million	158,000	158,000 $13 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.